His clinical interests are focused on the acute treatment and long-term management of schizophrenia, related psychotic disorders, and bipolar disorder. Areas of research interest include the conduct of longitudinal comparative effectiveness and comparative safety studies of pharmacotherapies for severe mental disorders and the use of automated health outcomes databases for evaluating comparative safety and reproductive outcomes of antipsychotic drugs, mood stabilizers, and antidepressants.